Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Kevzara (sarilumab) for the Treatment of Rheumatoid Arthritis

Drug (Brand / Generic)

Kevzara / sarilumab

Developers

Sanofi and Regeneron Pharmaceuticals

Therapy Class

Monoclonal antibody

Current Indication

Rheumatoid arthritis

Market Sector

Rheumatology

Development Status

Approved in the US and Canada, marketing authorisation under review in Europe
Expand

Go Top